|
1HEZ
Structure of P. magnus protein L bound to a human IgM Fab.
Deposited 2000-11-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
476–536(61 aa)
Fragment:820-880
|
Not recorded
|
IMD IMIDAZOLE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;13-16% MPEG 5000, 100MM IMIDAZOLE MALATE, PH8.5, pH 8.50
|
Resolution 2.70 Å
R-free 0.278
|
|
1YMH
anti-HCV Fab 19D9D6 complexed with protein L (PpL) mutant A66W
Deposited 2005-01-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
474–538(65 aa)
|
Mutation:A866W
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.1;293 K;9% PEG5K, 100mM Na cacodylate, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.60 Å
R-free 0.302
|
|
1YMH
anti-HCV Fab 19D9D6 complexed with protein L (PpL) mutant A66W
Deposited 2005-01-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
474–538(65 aa)
|
Mutation:A866W
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.1;293 K;9% PEG5K, 100mM Na cacodylate, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.60 Å
R-free 0.302
|
|
2FS1
solution structure of PSD-1
Deposited 2006-01-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
798–839(42 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 50 mM;Pressure ambient
NMR sample composition
0.2~0.4 mM PSD-1, 50 mM sodium phosphate buffer, pH 7.0, 0.1 mM EDTA, 10% D2O, 90% H2O | 10% D2O, 90% H2O
|
Resolution not provided
|
|
4IOI
Meditope-enabled trastuzumab in complex with CQFDLSTRRLKC
Deposited 2013-01-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
476–537(62 aa)
|
Mutation:T34I, D55A, Y73N, T74H, I75M
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.2;293 K;20% PEG 3350, 25 mM NaCl, 50 mM Hepes, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.95 Å
R-free 0.204
|
|
5U5F
MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT IN COMPLEX WITH (Ac) CQFDA(PH)2STRRLRCGGSK
Deposited 2016-12-06
|
Different mutation/modification
Different oligomeric state
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
477–537(61 aa)
|
Mutation:YES
|
MRY MESO-ERYTHRITOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.2;293 K;50 MM TRIS, PH 7.2, 50 MM NACL, 20%
PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
|
Resolution 1.81 Å
R-free 0.192
|
|
5U5M
CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO-MEDITOPE
Deposited 2016-12-06
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
477–537(61 aa)
|
Not recorded
|
MRY MESO-ERYTHRITOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.2;293 K;18 % PEG 3350, 150 MM NACL, 100 MM
TRIS, PH 7.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
|
Resolution 1.88 Å
R-free 0.197
|
|
5U6A
CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO-PEG3-MEDITOPE
Deposited 2016-12-07
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
479–537(59 aa)
|
Not recorded
|
MRY MESO-ERYTHRITOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;16% PEG 3350 200 MM NACL, PH 7.2
|
Resolution 1.74 Å
R-free 0.188
|
|
6B9Y
Trastuzumab Fab v3 in complex with 5-phenyl meditope variant
Deposited 2017-10-11
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
477–537(61 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Tris pH 7.5, 15% PEG3350, 24 mM NaCl
|
Resolution 2.14 Å
R-free 0.218
|
|
6B9Z
Trastuzumab Fab v3
Deposited 2017-10-11
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain E
477–537(61 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Tris, pH 7.5, 24 mM NaCl, 15% PEG3350
|
Resolution 1.82 Å
R-free 0.189
|
|
6BAE
Trastuzumab Fab v3 in complex with CQFDLSTRRLKC
Deposited 2017-10-12
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
477–537(61 aa)
|
Mutation:T17I, D38A, Y56N, T57H, I58M
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Tris pH 7.5, 24 mM NaCl, 15% PEG 3350
|
Resolution 2.14 Å
R-free 0.224
|
|
6BAH
Trastuzumab Fab v3 with 5-diphenyl meditope variant
Deposited 2017-10-12
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
477–537(61 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Tris, pH 7.5, 24 mM NaCl, 15% PEG 3350
|
Resolution 1.90 Å
R-free 0.194
|